In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

RELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...

Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...

Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefits Researchers at the American Diabetes Association conference in Orlando are expected to present data on 27 GLP-1 drugs in ...

Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These weight loss injections, GLP-1s like Wegovy, (same drug as Ozempic ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.